Delpharm secures corticoids manufacturing in France.
Published on
To address stock shortages of prednisolone and prednisone-based medicines, Delpharm has increased its capacity by acquiring a new, fully automated, high-speed packaging line at its Lille site.
Delpharm Lille has increased its corticoid production capacity significantly, from 8 to 20 million boxes a year.
Download the press release for more information
Delpharm press release
PDF - 128.8 KiB